Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine FDC Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Trial Profile

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine FDC Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Jan 2018

At a glance

  • Drugs Amlodipine/telmisartan (Primary) ; Telmisartan/hydrochlorothiazide (Primary) ; Amlodipine; Telmisartan
  • Indications Hypertension
  • Focus Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 30 Jan 2018 Status changed to active, no longer recruiting as per the investigators reply (druginfo.rdg@boehringer-ingelheim.com dated: 29 Jan 2018)
    • 22 Dec 2017 Planned End Date changed from 28 Dec 2017 to 12 Jan 2018.
    • 22 Dec 2017 Planned primary completion date changed from 28 Dec 2017 to 12 Jan 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top